Showing results (71-80 of 202) with videos related to
Sort By:
Pageof 21
Antibody Therapeutics|July 17, 2020
Highlights of Antibody Engineering and Therapeutics 2019 in San Diego, USA: Bispecific Antibody Design and Clinical ApplicationsYong Zhu, Run Shen, Rui Hao, et al.Antibody Therapeutics|January 17, 2020
Next-Generation Antibody Therapeutics: Discovery, Development and Beyond: highlights of the third annual conference of the Chinese Antibody SocietyHongyu Zhang, Mi Deng, Fen Pei, et al.Journal of Cancer|November 2, 2011
Rapid generation of in vitro multicellular spheroids for the study of monoclonal antibody therapyYen T Phung, Dario Barbone, V Courtney Broaddus, et al.Plos One|September 22, 2010
Epigenetic drugs can stimulate metastasis through enhanced expression of the pro-metastatic Ezrin geneYanlin Yu, Pingyao Zeng, Jingbo Xiong, et al.Nature Medicine|January 6, 2004
Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulatorsYanlin Yu, Javed Khan, Chand Khanna, et al.International Journal of Cancer|July 17, 2010
A novel high-affinity human monoclonal antibody to mesothelinMitchell Ho, Mingqian Feng, Robert J Fisher, et al.Mabs|January 13, 2010
Identification and characterization of fully human anti-CD22 monoclonal antibodiesXiaodong Xiao, Mitchell Ho, Zhongyu Zhu, et al.Mabs|July 24, 2012
High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screeningYen Phung, Wei Gao, Yan-Gao Man, et al.Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|May 7, 2013
[Pulmonary expression levels of fibroblast growth factor receptors and lung fibrosis in mice at different ages]Xiaoxi Li, Hongen Chang, Wenqing Nai, et al.International Journal of Molecular Sciences|May 11, 2024
Development of Personalized Strategies for Precisely Battling Malignant MelanomaArmond J Isaak, GeGe R Clements, Rand Gabriel M Buenaventura, et al.Pageof 21